Plasma and cerebrospinal fluid levels of baclofen (Lioresal) at optimal therapeutic responses in spastic paresis

J Neurol Sci. 1974 Nov;23(3):473-84. doi: 10.1016/0022-510x(74)90163-4.
No abstract available

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aminobutyrates / analogs & derivatives*
  • Cold Temperature
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Sclerosis / complications
  • Muscle Relaxants, Central / therapeutic use*
  • Muscle Spasticity / drug therapy*
  • Muscle Spasticity / physiopathology
  • Neurilemmoma / surgery
  • Paraplegia / complications
  • Peripheral Nervous System Neoplasms / surgery
  • Postoperative Complications
  • Quadriplegia / complications
  • Reflex, Stretch
  • Spinal Cord Injuries / complications
  • Spinal Neoplasms / complications
  • Time Factors
  • gamma-Aminobutyric Acid / analogs & derivatives*
  • gamma-Aminobutyric Acid / blood
  • gamma-Aminobutyric Acid / cerebrospinal fluid
  • gamma-Aminobutyric Acid / therapeutic use

Substances

  • Aminobutyrates
  • Muscle Relaxants, Central
  • gamma-Aminobutyric Acid